Singleron to present novel single cell sequencing solutions for blood cancer research at the 64th ASH Annual Meeting & Exposition
COLOGNE, Germany, Nov. 14, 2022 (GLOBE NEWSWIRE) — Singleron Biotechnologies, a pioneer in development and commercialization of innovative single cell sequencing analysis solutions for precision medicine, announced today their participation in the upcoming 64th American Society of Hematology (ASH) Annual